- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We’re Reading: FDA Clears First Monthly Shot for HIV; Biologic for COVID-19 Shows Promise; Food Aid to Rise
The FDA approved the first injectable monthly treatment for HIV; Eli Lilly announced positive effects of its monoclonal antibody treatment for coronavirus disease 2019 (COVID-19); President Joe Biden will sign an executive order on food insecurity.
FDA Approves First Monthly Injectable HIV Treatment
The FDA approved the first extended-release injectable drug regimen for people living with HIV. The approval for cabotegravir and rilpivirine, to be sold as Cabenuva, replaces a daily oral 3-drug regimen with 1 monthly injection. Janssen makes rilpivirine and ViiV Healthcare makes cabotegravir. The New York Times reported that female patients, in particular, like the once-a-month treatment option.
Eli Lilly Reports Positive Results of Monoclonal Antibody for COVID-19
Eli Lilly announced its monoclonal antibody treatment cut the risk of developing symptomatic coronavirus disease 2019 (COVID-19) among nursing home residents, USA Today reports. Study results have yet to be published, but according to the company, of 299 individuals—half of whom received bamlanivimab—those who took the drug had up to an 80% lower risk of contracting COVID-19 compared with the placebo arm. Health care providers at the nursing homes also received a 4200-mg dose and were statistically less likely to contract symptomatic COVID-19. Four residents died in the placebo group while there were no deaths among the 41 residents who already tested positive for COVID-19 and received the monoclonal antibody.
Biden to Sign Executive Order Curbing Food Insecurity
President Joe Biden is slated to sign an executive order aimed at increasing food aid to children who normally rely on school meals for nutrition, Reuters reports. Current estimates suggest 29 million Americans don’t have enough to eat as a result of the pandemic. The order is not intended to be a substitute for comprehensive legislative relief but can provide interim support while legislation is negotiated in Congress. As part of the order, the president will ask the Agriculture Department (USDA) to consider using new guidance to increase aid to families. The aid has the potential to provide a family with 3 children more than $100 of additional support every 2 months.
The Impact of Cost-Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
PAH Treatment Benefits Extend to Patients With Repaired Congenital Heart Disease
March 14th 2025Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ranges from 4% to 28%, according to studies from the US and Europe—and that the prevalence of these comorbid condition is on the rise.
Read More
Regenerating Neurons, Muscle, and Hope in the Field of Muscular Dystrophy
March 13th 2025The 2025 Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature clinical updates, expert insights, and breaking trial findings that sum up to a new frontier of care for neuromuscular diseases.
Read More
